Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Total Liabilities: 2020-2025

Historic Total Liabilities for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $1.3 billion.

  • Agilon Health's Total Liabilities fell 1492.68% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 1492.68%. This contributed to the annual value of $1.3 billion for FY2024, which is 1696.41% up from last year.
  • According to the latest figures from Q3 2025, Agilon Health's Total Liabilities is $1.3 billion, which was down 1492.68% from $1.3 billion recorded in Q2 2025.
  • Agilon Health's Total Liabilities' 5-year high stood at $1.6 billion during Q1 2024, with a 5-year trough of $494.7 million in Q4 2021.
  • Moreover, its 5-year median value for Total Liabilities was $1.1 billion (2023), whereas its average is $1.1 billion.
  • As far as peak fluctuations go, Agilon Health's Total Liabilities skyrocketed by 9988.78% in 2023, and later crashed by 1492.68% in 2025.
  • Over the past 5 years, Agilon Health's Total Liabilities (Quarter) stood at $494.7 million in 2021, then soared by 32.79% to $656.9 million in 2022, then soared by 64.4% to $1.1 billion in 2023, then rose by 16.96% to $1.3 billion in 2024, then rose by 2.15% to $1.3 billion in 2025.
  • Its Total Liabilities stands at $1.3 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.4 billion for Q1 2025.